Banque Pictet & Cie’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.2M Sell
199,740
-2,513
-1% -$331K 0.16% 59
2026
Q1
$28.2M Sell
202,253
-24,754
-11% -$3.47M 0.2% 55
2025
Q4
$27.9M Buy
227,007
+142,543
+169% +$17.3M 0.16% 55
2025
Q3
$9.38M Buy
84,464
+9,878
+13% +$1.12M 0.05% 114
2025
Q2
$8.27M Buy
74,586
+37,633
+102% +$4.01M 0.06% 118
2025
Q1
$4.14M Sell
36,953
-14,668
-28% -$1.51M 0.03% 161
2024
Q4
$4.77M Buy
51,621
+46,121
+839% +$4.15M 0.03% 156
2024
Q3
$461K Hold
5,500
﹤0.01% 268
2024
Q2
$377K Hold
5,500
﹤0.01% 275
2024
Q1
$403K Hold
5,500
﹤0.01% 291
2023
Q4
$446K Sell
5,500
-1,976
-26% -$154K ﹤0.01% 278
2023
Q3
$560K Sell
7,476
-4,152
-36% -$319K 0.01% 321
2023
Q2
$896K Sell
11,628
-903
-7% -$72K 0.01% 340
2023
Q1
$1.04M Sell
12,531
-2,854
-19% -$236K 0.01% 377
2022
Q4
$1.32M Sell
15,385
-2,907
-16% -$230K 0.01% 353
2022
Q3
$1.13M Sell
18,292
-9,130
-33% -$576K 0.01% 375
2022
Q2
$1.7K Sell
27,422
-49,893
-65% -$3.09M 0.02% 331
2022
Q1
$4.6M Buy
77,315
+33,558
+77% +$2.15M 0.04% 197
2021
Q4
$3.18M Buy
43,757
+631
+1% +$43.5K 0.02% 259
2021
Q3
$3.01M Buy
43,126
+350
+0.8% +$24.6K 0.03% 175
2021
Q2
$2.95M Sell
42,776
-3,000
-7% -$200K 0.03% 179
2021
Q1
$2.96M Sell
45,776
-13,650
-23% -$880K 0.04% 176
2020
Q4
$3.46M Sell
59,426
-2,364
-4% -$143K 0.05% 162
2020
Q3
$3.9M Sell
61,790
-5,600
-8% -$388K 0.06% 153
2020
Q2
$5.18M Sell
67,390
-9,881
-13% -$757K 0.09% 129
2020
Q1
$5.78M Sell
77,271
-85,548
-53% -$5.91M 0.12% 97
2019
Q4
$10.6M Buy
162,819
+2,685
+2% +$175K 0.18% 82
2019
Q3
$10.1M Buy
160,134
+5,810
+4% +$380K 0.19% 75
2019
Q2
$10.4M Buy
154,324
+9,187
+6% +$604K 0.19% 72
2019
Q1
$9.44M Sell
145,137
-13,201
-8% -$877K 0.18% 77
2018
Q4
$9.9M Buy
158,338
+4,115
+3% +$288K 0.2% 75
2018
Q3
$11.9M Buy
154,223
+1,542
+1% +$116K 0.22% 73
2018
Q2
$10.8M Buy
152,681
+18,527
+14% +$1.31M 0.21% 78
2018
Q1
$10.1M Sell
134,154
-2,243
-2% -$178K 0.21% 80
2017
Q4
$9.77M Sell
136,397
-13,718
-9% -$1.04M 0.2% 75
2017
Q3
$12.2M Sell
150,115
-54,241
-27% -$4.15M 0.28% 67
2017
Q2
$14.5M Buy
204,356
+21,737
+12% +$1.45M 0.34% 52
2017
Q1
$12.4M Buy
182,619
+34,140
+23% +$2.4M 0.31% 65
2016
Q4
$10.6M Buy
148,479
+2,714
+2% +$202K 0.27% 70
2016
Q3
$11.5M Sell
145,765
-148,024
-50% -$12M 0.3% 65
2016
Q2
$24.5M Sell
293,789
-61,200
-17% -$5.43M 0.66% 40
2016
Q1
$32.6M Sell
354,989
-29,373
-8% -$2.65M 0.85% 32
2015
Q4
$38.9M Buy
384,362
+170,328
+80% +$17.7M 1.05% 29
2015
Q3
$21M Buy
+214,034
New +$23.8M 0.63% 40
2015
Q2
Sell
-210,678
Closed -$20.7M 389
2015
Q1
$20.7M Sell
210,678
-1,484
-0.7% -$151K 0.54% 45
2014
Q4
$20M Sell
212,162
-27,720
-12% -$2.87M 0.53% 46
2014
Q3
$25.5M Buy
239,882
+11,959
+5% +$1.17M 0.66% 39
2014
Q2
$18.9M Buy
227,923
+116,959
+105% +$9.1M 0.47% 46
2014
Q1
$7.86M Buy
110,964
+7,601
+7% +$596K 0.22% 80
2013
Q4
$7.77M Buy
+103,363
New +$7.2M 0.23% 78

Other funds holding GILD

Banque Pictet & Cie's GILD Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $331K and leaving 199,740 shares worth $25.2M. The position accounts for 0.16% of the portfolio, ranked #59.

Banque Pictet & Cie first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $38.9M in Q4 2015. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Banque Pictet & Cie held 199,740 shares of Gilead Sciences worth $25.2M as of Q2 2026.
  • Banque Pictet & Cie sold 2,513 Gilead Sciences shares in Q2 2026, an estimated $331K.
  • Gilead Sciences made up 0.16% of Banque Pictet & Cie's portfolio in Q2 2026, its #59 holding.
  • Banque Pictet & Cie first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Banque Pictet & Cie's Gilead Sciences position peaked at $38.9M in Q4 2015.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.